| abstract |
The present invention relates to (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4, 5-dihydro-1H-pyrazole-3-carboxamide • X H 2 O, with X between 0.7 and 0.3. nEspecially preferred is (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4dichlorophenyl)-4, 5-dihydro-1H-pyrazole-3-carboxamide • monhydrate. nMethods of preparation and their use as modulators of the cannabinoid receptor are also disclosed. |